磷酸肌酸钠联合单唾液酸四己糖神经节苷脂钠治疗新生儿缺氧缺血性脑病临床疗效观察.pdf

黑龙江医学 第 45 卷 2021 年 第 7 期
750 HEILONGJIANG MEDICAL JOURNAL score and NSE,cTnI,CK-MB levels were compared between the two groups before and after treatment and
the incidence of adverse reactions in the two groups was statistically :After treatment,the NBNA score of group
B was higher than that of group A,the difference was statistically significant (P<).After treatment,the levels of NSE,CTN I,
CK-MB in group B were lower than those in group A,the difference was statistically significant (P<).No serious adverse drug
reactions occurred in both groups during the :Creatine phosphate sodium combined with monosialotetrahexo-
sylganglioside sodium has good clinical efficacy in the treatment of HIE,and does not increase the risk of drug use,so it is worthy
of clinical promotion.
Key words Neonatal hypoxic ischemic encephalopathy;Creatine phosphate sodium;Monosialotetrahexosylganglioside sodium;
Nerve function;myocardial injury
缺氧缺血性脑病（HIE）是一种由脑组织缺血、缺氧 例 HIE 患儿分为 A、B 两组（A=40，B=40）。A 组男性 20
引发的脑组织病变，多发于新生儿，是新生儿窒息患儿极 例，女性 20 例；胎龄 37～41 周，平均胎龄（?）
为严重的一种神经系统并发症。病情较为严重的 HIE 患儿 周；日龄